Monotherapy with GLP-1 receptor agonist, lixisenatide, significantly improves glycaemic control in type 2 diabetic patients [abstract 830]
Semaglutide: A Strong Contender Wegovy, known generically as Semaglutide, has become widely recognized for its substantial efficacy in promoting weight loss
Endocrinology 153 , 38783885 (2012)
The best course of action with any GLP-1 treatment is to continue your treatment plan for as long as possible to ensure you get maximum benefits
While they work best when combined with a balanced diet and regular exercise, GLP-1s not only lower weight for many but can also reduce weight-related health risks such as high blood pressure, elevated blood sugar levels, and heart-related issues
Users often experience a warm, sweaty, energized sensationsignaling elevated heat production and calorie burning